Valor-qi program
1 paper2 findings
- 1 lab
- Human trial1
Outcomes
2Patients with LDL-C >100 mg/dL
downin humans1
1 study
Patients with LDL-C >100 mg/dL
downin humans1
Valor-qi program decreases patients with LDL-C >100 mg/dL in humans (78% to 49%).
“and the proportion with levels >100 mg/dL dropped to 49%”
Human trialVeterans with ASCVD and baseline LDL-C >70 mg/dLAugust 2023 through May 2025n = 96
AHA Scientific Sessions 2025 abstract3 Nov 2025
Patients with LDL-C <70 mg/dL
upin humans1
1 study
Patients with LDL-C <70 mg/dL
upin humans1
Valor-qi program increases patients with LDL-C <70 mg/dL in humans.
“By May 2025, 33% had reached the target of LDL-C <70 mg/dL”
Human trialVeterans with ASCVD and baseline LDL-C >70 mg/dLAugust 2023 through May 2025n = 96
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Enhancing Lipid Management in Veterans: Integrating Whole Health Principles through the VALOR-QI Program and Veterans Health Administration
Non-randomised trial in 96 peopleInterventions